Raymond James & Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-16,900
Closed -$30K 4223
2021
Q1
$30K Buy
+16,900
New +$275K ﹤0.01% 3891
2019
Q1
Sell
-20,000
Closed -$39K 3724
2018
Q4
$39K Buy
+20,000
New +$648K ﹤0.01% 3406

Other funds holding VTRS

Raymond James & Associates's VTRS Position: Q3 2024 in Review

Raymond James & Associates increased its Viatris (VTRS) stake by 6% in Q3 2024, buying an estimated $917K and bringing the position to 1,406,036 shares worth $16.3M. The position accounts for 0.01% of the portfolio, ranked #931.

Raymond James & Associates first reported a position in VTRS in Q2 2013 and has held it in 46 quarters since. The position peaked at $26.9M in Q2 2017. 1,002 funds tracked by Wall St. Rank hold VTRS as of Q3 2024.

  • Raymond James & Associates held 1,406,036 shares of Viatris worth $16.3M as of Q3 2024.
  • Raymond James & Associates bought 79,494 Viatris shares in Q3 2024, an estimated $917K.
  • Viatris made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #931 holding.
  • Raymond James & Associates first reported a position in Viatris in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Viatris position peaked at $26.9M in Q2 2017.
  • 1,002 funds tracked by Wall St. Rank held Viatris as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.